Down‐regulation of caveolin‐1 in glioma vasculature: Modulation by radiotherapy
- 1 December 2003
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 75 (2) , 291-299
- https://doi.org/10.1002/jnr.10865
Abstract
Primary brain tumors, particularly glioblastomas (GB), remain a challenge for oncology. An element of the malignant brain tumors' aggressive behavior is the fact that GB are among the most densely vascularized tumors. To determine some of the molecular regulations occuring at the brain tumor endothelium level during tumoral progression would be an asset in understanding brain tumor biology. Caveolin‐1 is an essential structural constituent of caveolae that has been implicated in mitogenic signaling, oncogenesis, and angiogenesis. In this work we investigated regulation of caveolin‐1 expression in brain endothelial cells (ECs) under angiogenic conditions. In vitro, brain EC caveolin‐1 is down‐regulated by angiogenic factors treament and by hypoxia. Coculture of brain ECs with tumoral cells induced a similar down‐regulation. In addition, activation of the p42/44 MAP kinase is demonstrated. By using an in vivo brain tumor model, we purified ECs from gliomas as well as from normal brain to investigate possible regulation of caveolin‐1 expression in tumoral brain vasculature. We show that caveolin‐1 expression is strikingly down‐regulated in glioma ECs, whereas an increase of phosphorylated caveolin‐1 is observed. Whole‐brain radiation treatment, a classical way in which GB is currently being treated, resulted in increased caveolin‐1 expression in tumor isolated ECs. The level of tumor cells spreading around newly formed blood vessels was also elevated. The regulation of caveolin‐1 expression in tumoral ECs may reflect the tumoral vasculature state and correlates with angiogenesis kinetics.Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada
- Cancer Research Society
This publication has 31 references indexed in Scilit:
- Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblastsAmerican Journal of Physiology-Cell Physiology, 2003
- Respiratory syncytial virus assembly occurs in GM1-rich regions of the host-cell membrane and alters the cellular distribution of tyrosine phosphorylated caveolin-1Journal of General Virology, 2002
- Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cellsOncogene, 2002
- Regulation of MAP kinases by docking domainsBiology of the Cell, 2001
- Isolation of Endothelial Cells from Brain, Lung, and Kidney: Expression of the Multidrug Resistance P-Glycoprotein IsoformsBiochemical and Biophysical Research Communications, 2001
- In vitro model for evaluating drug transport across the blood–brain barrierPublished by Elsevier ,1999
- Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascadeThe EMBO Journal, 1998
- Caveolin‐mediated regulation of signaling along the p42/44 MAP kinase cascade in vivoFEBS Letters, 1998
- Recombinant Expression of Caveolin-1 in Oncogenically Transformed Cells Abrogates Anchorage-independent GrowthJournal of Biological Chemistry, 1997
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995